NCT00541723 - Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles | Biotech Hunter

Enrollment

111

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

May 31, 2008

Conditions

Lateral Periorbital Wrinkles

Interventions

DRUG

IncobotulinumtoxinA (Xeomin)

Intramuscular injection at day 0, at 3 and 4 injection sites per eye (4 x 3 or 3 x 4 units = 12 units per eye)

DRUG

Placebo

Intramuscular injection at day 0, at 3 and 4 injection sites per eye.

Trial Locations (12)

Cannes

Nice

Paris

Düsseldorf

Karlsruhe

Munich

Starnberg

Roma

Bexley. Kent

Glasgow

London

Sutton Coldfield